Iris Otero-Luis

Dr. Iris Otero-Luis

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
CPCarlos Pascual-Morena
Carlos Pascual-Morena
IOIris Otero-Luis
Iris Otero-Luis
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
MMMARTA FENOLL MORANTE
MARTA FENOLL MORANTE
Background/Objectives: Age is a known predictor of skin autofluorescence (SAF) across populations, but age-based reference values are lacking for the Spanish population. This study aims to establish SAF reference values for healthy Spanish adults by age group, compare these with other populations, and estimate optimal SAF cut-off points by age range. Additionally, it aims to analyse the influence of sex, smoking, and skin phototype. Methods: This cross-sectional EVasCu study included 390 healthy subjects aged over 18 years. Participants’ age, sex, smoking status, and skin were recorded and categorised into age groups. Advanced glycation end products were measured through the SAF. A systematic review and meta-analysis, including an EVasCu study, was performed to obtain pooled means and standard deviations by age group. Results: The mean SAF Spanish values by age were (95% CI): (i) 18–19 years: 1.34–1.56 arbitrary units (AU); (ii) 20–29 years: 1.56–1.70 AU; (iii) 30–39 years: 1.66–1.84 AU; (iv) 40–49 years: 1.79–1.91 AU; (v) 50–59 years: 2.07–2.21 AU; (vi) ≥60 years: 2.07–2.50 AU. SAF was significantly correlated with age (r = 0.531; p < 0.001), smoking status (r = −0.196; p < 0.001), and skin phototype (r = 0.138; p = 0.007), and SAF was greater in smokers and dark-skinned individuals (p < 0.05). No significant differences were found in the SAF values for sex. The results of the meta-analysis were in line with those of the present study, providing reference values of SAF for the general population. Conclusions: SAF increases linearly with age in healthy individuals, and higher levels of SAF are observed in smokers and dark-skinned individuals.

28 February 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
ICIván Cavero-Redondo
Iván Cavero-Redondo
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
ASAlicia Saz-Lara
Alicia Saz-Lara
Background: Spasticity is a very common neurological sequelae that significantly impacts the quality of life of patients, affecting more than 12 million people worldwide. Botulinum toxin is considered a reversible treatment for spasticity, but due to the large amount of available evidence, synthesis seems necessary. Therefore, we conducted an overview of existing systematic reviews and meta-analyses to evaluate the effect of botulinum toxin injections in the treatment of spasticity of different etiologies. Methods: A systematic search of different databases, including Pubmed, Scopus, the Cochrane Library, and Web of Science, was performed from inception to February 2024. Standardized mean differences (SMDs) and their respective 95% confidence intervals (CIs) were calculated to assess the effect of botulinum toxin compared to that of the control treatment using the Modified Ashworth Scale (MAS). All the statistical analyses were performed using STATA 15 software. Results: 28 studies were included in the umbrella review. The effect of botulinum toxin injections on spasticity, as measured by the MAS, was significantly lower in all but three studies, although these studies also supported the intervention. The SMDs reported by the meta-analyses ranged from −0.98 to −0.01. Conclusion: Botulinum toxin injections were effective at treating spasticity of different etiologies, as indicated by the measurements on the MAS. This implies an improvement in muscle tone and, consequently, in the patient’s mobility and quality of life.

3 May 2024 in Health Information Science and Systems
Verified
Journal Article
Closed access
PDF file
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
José Carlos CastilloJosé Carlos Castillo
José Carlos Castillo
ASAlicia Saz-Lara
Alicia Saz-Lara
IOIris Otero-Luis
Iris Otero-Luis
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo

6 July 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
IOIris Otero-Luis
Iris Otero-Luis
ASAlicia Saz-Lara
Alicia Saz-Lara
NMNerea Moreno-Herraiz
Nerea Moreno-Herraiz
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
BPBruno Bizzozero Peroni
Bruno Bizzozero Peroni
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
(1) Background: Previous evidence has indicated a connection between a Mediterranean diet and cardiovascular disease. However, evidence for subclinical markers of cardiovascular disease, such as arterial stiffness, is limited. Therefore, the aim of this study was to assess the associations between adherence to the Mediterranean diet (MD), as assessed by the MEDAS-14 questionnaire, and arterial stiffness, as assessed by aortic pulse wave velocity, in healthy adults and according to sex. (2) A cross-sectional study including 386 healthy participants was performed in the EVasCu study. Adjusted and unadjusted differences in adherence to the MD and arterial stiffness were determined using Student’s t test and ANCOVA for the total sample and according to sex. (3) Results: Our results showed that individuals with a high adherence to the MD had a greater arterial stiffness, both in the total sample and in females, although this difference was not significant after adjusting for possible confounding variables, such as age. (4) Conclusions: Our findings indicated that, in the unadjusted analyses, healthy subjects with a high adherence to the MD showed a greater arterial stiffness. When these analyses were adjusted, no significant differences were shown in a-PWv according to the categories of MD adherence.

20 December 2024 in PLOS ONE
Verified
Journal Article
Open access
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
HFHelder Fonseca
Helder Fonseca
IOIris Otero-Luis
Iris Otero-Luis
LBLucimere Bohn
Lucimere Bohn
CLCarla Geovanna Lever-Megina
Carla Geovanna Lever-Megina
ASAlicia Saz-Lara
Alicia Saz-Lara
Background: As individuals age, the risk of cardiovascular disease (CVD) increases, largely due to progressive stiffening of the arteries. This relationship underscores the critical need to monitor arterial stiffness as a predictor of CVD outcomes. While aerobic exercise has demonstrated benefits for vascular health, the influence of flexibility, particularly trunk flexibility, on arterial stiffness remains underexplored. Thus, this study aimed to analyse the overall relationship between trunk flexibility and arterial stiffness across different age groups (young, middle-aged, and older adults) and according to sex. Methods: A systematic review and meta-analysis were conducted following the MOOSE and JBI Manual for Evidence Synthesis on systematic reviews of etiology and risk guidelines. Searches in PubMed, Scopus, and Web of Science identified studies investigating the association between trunk flexibility and arterial stiffness measured by pulse wave velocity. Data extraction, quality assessment, and statistical analyses were performed following predefined criteria. Results: Five studies involving 2797 participants were included. Poor trunk flexibility was associated with increased arterial stiffness compared to high flexibility (pooled standardized mean difference = -0.27, 95% CI: -0.39, -0.14), with substantial heterogeneity observed. Subgroup analyses by sex and age revealed significant associations predominantly in men and older individuals. Sensitivity analyses confirmed the robustness of the findings, and meta-regression models showed no significant differences according to age, BMI, or blood pressure. No evidence of publication bias was found. Conclusion: Poor trunk flexibility is linked to elevated arterial stiffness across diverse demographic groups, highlighting its potential as a surrogate marker for cardiovascular health. Physiological mechanisms involving connective tissue integrity and neural regulation may underpin this relationship. Understanding the role of flexibility in arterial health could inform targeted interventions to mitigate age-related increases in arterial stiffness and reduce cardiovascular disease risk. However, further research is needed to validate these findings and explore potential sex-specific differences.

ASAlicia Saz-Lara
Alicia Saz-Lara
AMArturo Martinez-Rodrigo
Arturo Martinez-Rodrigo
EGEva Galan-Moya
Eva Galan-Moya
Irene Martínez GarcíaIrene Martínez García
Irene Martínez García
IOIris Otero-Luis
Iris Otero-Luis
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Recent evidence suggests that sex-related differences in cardiovascular health extend beyond traditional risk factors, affecting vascular structure and function. This study aimed to examine sex differences in vascular parameters, including central and peripheral blood pressure, pulse wave velocity (PWv), augmentation index at 75 bpm (AIx75), cardiac output, stroke volume, and peripheral vascular resistance, using harmonized data from three population-based cohorts (EVasCu, VascuNET, and ExIC-FEp) as part of the MUJER-EVA project. A total of 669 adult participants were included in this pooled cross-sectional analysis. Sex-stratified comparisons were conducted using multiple linear regression models adjusted for anthropometric, sociodemographic, and clinical covariates. The results showed that men had significantly higher values for central and peripheral blood pressure (p < 0.001), PWv (p = 0.003), cardiac output (p < 0.001), and stroke volume (p < 0.001), whereas women presented higher values of AIx75 (p < 0.001) and peripheral vascular resistance (p = 0.002). These differences remained statistically significant after full adjustment for potential confounders. These findings highlight the need to consider sex as a key biological variable in cardiovascular research and clinical decision-making. Incorporating sex-specific reference values and personalized treatment strategies could improve vascular health assessment and the effectiveness of cardiovascular disease prevention.